Description
This advanced triple-peptide formulation integrates the copper-coordinated ECM remodeling activity of GHK-Cu with the angiogenic VEGFR2 signaling of BPC-157 and the actin-regulatory cell migration properties of TB-500. It serves as a comprehensive research reagent for studying convergent tissue repair mechanisms. For research use only.
- Tri-Axis Tissue Repair Modeling: Investigated for the convergent activation of TGF-β-driven collagen synthesis (GHK-Cu), VEGFR2-mediated neovascularization (BPC-157), and lamellipodial cell migration (TB-500).
- Matrix Metalloproteinase Regulation: Studied for coordinated MMP-2/MMP-9 modulation across all three peptide pathways and the resulting effects on ECM turnover kinetics.
- Integrated Antioxidant & Anti-Inflammatory Response: Explored for combined Nrf2/ARE activation (GHK-Cu), NO system regulation (BPC-157), and cytokine suppression (TB-500) in complex inflammatory tissue models.









Reviews
There are no reviews yet.